Inhaled granulocyte/macrophage colony-stimulating factor as treatment of pneumonia-associated acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 5, 2014, Pages 609-611

  Herold, Susanne ^a   Hoegner, Katrin ^a   Vadá Sz, Istvan ^a   Gessler, Tobias ^a   Wilhelm, Jochen ^a   Mayer, Konstantin ^a   Morty, Rory E ^a,b   Walmrath, Hans Dieter ^a   Seeger, Werner ^a   Lohmeyer, Juergen ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMPASSIONATE USE; CONTROLLED STUDY; DENDRITIC CELL; EXTRACORPOREAL OXYGENATION; HEALTH CARE; HOST RESISTANCE; HUMAN; LETTER; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG COMPLIANCE; LUNG GAS EXCHANGE; NEBULIZATION; NEBULIZER; OXYGENATION; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FUNCTION; VENTILATOR ASSOCIATED PNEUMONIA;

ADMINISTRATION, INHALATION; DRUG ADMINISTRATION SCHEDULE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LINEAR MODELS; PNEUMONIA; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY SYSTEM AGENTS; TREATMENT OUTCOME;

EID: 84895540774     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201311-2041LE     Document Type: Letter

References (14)

1. Huang FF, Barnes PF, Feng Y, Donis R, Chroneos ZC, Idell S, Allen T, Perez DR, Whitsett JA, Dunussi-Joannopoulos K, et al. GM-CSF in the lung protects against lethal influenza infection. Am J Respir Crit Care Med 2011;184:259-268.
2. Standiford LR, Standiford TJ, Newstead MJ, Zeng X, Ballinger MN, Kovach MA, Reka AK, Bhan U. TLR4-dependent GM-CSF protects against lung injury in Gram-negative bacterial pneumonia. Am J Physiol Lung Cell Mol Physiol 2012;302:L447-L454.
3. Steinwede K, Tempelhof O, Bolte K, Maus R, Bohling J, Ueberberg B, L̈anger F, Christman JW, Paton JC, Ask K, et al. Local delivery of GM-CSF protects mice from lethal pneumococcal pneumonia. J Immunol 2011;187:5346-5356.
4. Unkel B, Hoegner K, Clausen BE, Lewe-Schlosser P, Bodner J, Gattenloehner S, Janßen H, Seeger W, Lohmeyer J, Herold S. Alveolar epithelial cells orchestrate DC function in murine viral pneumonia. J Clin Invest 2012;122:3652-3664.
5. Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M, Udalova IA. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 2011;12:231-238.
6. Trapnell BC, Carey BC, Uchida K, Suzuki T. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages. Curr Opin Immunol 2009;21:514-521.
7. Sturrock A, Seedahmed E, Mir-Kasimov M, Boltax J, McManus ML, Paine R III. GM-CSF provides autocrine protection for murine alveolar epithelial cells from oxidant-induced mitochondrial injury. Am J Physiol Lung Cell Mol Physiol 2012;302:L343-L351.
8. Cakarova L, Marsh LM, Wilhelm J, Mayer K, Grimminger F, Seeger W, Lohmeyer J, Herold S. Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair. Am J Respir Crit Care Med 2009;180:521-532.
9. Matute-Bello G, Liles WC, Radella F II, Steinberg KP, Ruzinski JT, Hudson LD, Martin TR. Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit Care Med 2000;28:1-7.
10. Presneill JJ, Harris T, Stewart AG, Cade JF, Wilson JW. A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am J Respir Crit Care Med 2002;166:138-143.
11. Quinton LJ. GM-CSF: a double dose of protection during pneumonia. Am J Physiol Lung Cell Mol Physiol 2012;302:L445-L446.
12. Paine R III, Standiford TJ, Dechert RE, Moss M, Martin GS, Rosenberg AL, Thannickal VJ, Burnham EL, Brown MB, Hyzy RC. A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury. Crit Care Med 2012;40:90-97.
13. LuisettiM, Kroneberg P, Suzuki T, Kadija Z, Muellinger B, Campo I, Gleske J, Rodi G, Zimlich WC, Mariani F, et al. Physical properties, lung deposition modeling, and bioactivity of recombinant GM-CSF aerosolised with a highly efficient nebulizer. Pulm Pharmacol Ther 2011;24:123-127.
14. Ambarus CA, Krausz S, van Eijk M, Hamann J, Radstake TR, Reedquist KA, Tak PP, Baeten DL. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J Immunol Methods 2012;375:196-206.